Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
145.55
-2.76 (-1.86%)
At close: Feb 25, 2026, 4:00 PM EST
145.75
+0.20 (0.14%)
After-hours: Feb 25, 2026, 7:44 PM EST
Molina Healthcare Stock Forecast
Stock Price Forecast
The 12 analysts that cover Molina Healthcare stock have a consensus rating of "Hold" and an average price target of $176.5, which forecasts a 21.26% increase in the stock price over the next year. The lowest target is $124 and the highest is $330.
Price Target: $176.5 (+21.26%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 9 | 9 | 9 | 9 | 9 | 10 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $208 → $141 | Buy → Hold | Downgrades | $208 → $141 | -3.13% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $190 → $145 | Hold | Maintains | $190 → $145 | -0.38% | Feb 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $167 → $124 | Hold | Maintains | $167 → $124 | -14.81% | Feb 12, 2026 |
| Barclays | Barclays | Sell Maintains $164 → $133 | Sell | Maintains | $164 → $133 | -8.62% | Feb 10, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $175 → $144 | Hold | Maintains | $175 → $144 | -1.06% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
45.44B
from 43.56B
Increased by 4.30%
Revenue Next Year
48.34B
from 45.44B
Increased by 6.38%
EPS This Year
13.90
from 8.92
Increased by 55.85%
EPS Next Year
16.33
from 13.90
Increased by 17.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.0B | 53.5B | |||
| Avg | 45.4B | 48.3B | |||
| Low | 42.8B | 44.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.6% | 17.8% | |||
| Avg | 4.3% | 6.4% | |||
| Low | -1.7% | -3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.26 | 19.48 | |||
| Avg | 13.90 | 16.33 | |||
| Low | 10.78 | 11.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 93.5% | 40.1% | |||
| Avg | 55.9% | 17.5% | |||
| Low | 20.9% | -15.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.